» Articles » PMID: 30357878

A Method for Determining Groups in Multiple Survival Curves

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2018 Oct 26
PMID 30357878
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Survival analysis includes a wide variety of methods for analyzing time-to-event data. One basic but important goal in survival analysis is the comparison of survival curves between groups. Several nonparametric methods have been proposed in the literature to test for the equality of survival curves for censored data. When the null hypothesis of equality of curves is rejected, leading to the clear conclusion that at least one curve is different, it can be interesting to ascertain whether curves can be grouped or if all these curves are different from each other. A method is proposed that allows determining groups with an automatic selection of their number. The validity and behavior of the proposed method was evaluated through simulation studies. The applicability of the proposed method is illustrated using real data. Software in the form of an R package has been developed implementing the proposed method.

Citing Articles

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease.

Kendall T, Jimenez-Ramos M, Turner F, Ramachandran P, Minnier J, McColgan M Nat Med. 2023; 29(11):2939-2953.

PMID: 37903863 PMC: 10667096. DOI: 10.1038/s41591-023-02602-2.


Machine learning of COVID-19 clinical data identifies population structures with therapeutic potential.

Greenwood D, Taverner T, Adderley N, Price M, Gokhale K, Sainsbury C iScience. 2022; 25(7):104480.

PMID: 35665240 PMC: 9153184. DOI: 10.1016/j.isci.2022.104480.


Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer.

Murugan S, Rousseau B, Sarkar D Cancers (Basel). 2021; 13(19).

PMID: 34638341 PMC: 8508249. DOI: 10.3390/cancers13194858.